Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines - WGS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Verra Mobility Corporation of Class Action Lawsuit and Upcoming Deadlines - VRRM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuit, Inc. - INTU

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BP p.l.c. - BP

Clinical trial NCT06100939 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-10-01 → 2026-06-12 3. primary completion date: 2025-10-01 → 2026-05-27 4. enrollment: 400 → 396 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05318105 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-12-31 → 2026-04-07 3. primary completion date: 2026-09-30 → 2025-10-06 4. enrollment: 372 → 167 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07498140: collaborators added: First Lviv Medical Union.

Clinical trial NCT07652658 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-15 → 2026-06-11 3. completion date: 2028-09-18 → 2028-09-14 4. primary completion date: 2028-09-18 → 2028-09-14